Optimization of Lead Compound is stage two of the drug discovery process at Gilga-Med. However, the models are still verified only against mouse studies.

Once optimal pK (result of pharmacokinetic studies) is established, we move on to stage three. 

pK studies involve taking blood samples over time to learn how the body reacts to the drug.